Uno de los retos a los que debe enfrentarse la nefrología moderna es el de identificar
biomarcadores que se asocien a patrones anatomopatológicos oa mecanismos …

One of the major challenges modern nephrology should face is the identification of
biomarkers that are associated with histopathological patterns or defined pathogenic …

Recent advances in glomerular biology have expanded our understanding of glomerular
diseases, leading to more precise therapeutic options. Since the discovery of the …

The diagnosis and treatment decisions in glomerular disease are principally based on renal
pathology and nonspecific clinical laboratory measurements such as serum creatinine and …

In the past decade there has been a sea change in the way disease is diagnosed and
investigated due to the advent of high throughput technologies, such as microarrays, lab on …

Animal models and human studies have been useful in dissecting the molecular
mechanisms of renal disease and finding new disease targets; however, translation of these …

Chronic kidney disease (CKD) remains to be one of the highest public health burdens
worldwide with high-prevalence among the general population. The heterogeneity of the …

Proteomic biomarkers offer the hope of improving the management of patients with kidney
diseases by enabling more accurate and earlier detection of renal pathology than is …

An increasing number of patients suffering from renal diseases and limitations in standard
diagnostic and therapeutic approaches has created an intense interest in applying …

Prognosis, risk stratification and monitoring the effects of treatment are fundamental
elements in the decision-making process when implementing prevention strategies for …